Muscle Physiology and DisordersPharmacology and Obesity TreatmentNutrition and Health in Aging

Long-Term Safety of Givinostat in Patients with Duchenne Muscular Dystrophy: Interim Results from an Open-Label Extension Study

K. Gilling, J. Brandsema, G. Acsadi, F. Alessi, P. Bettica, O. Boespflug-Tanguy, M. Guglieri, A. Blaschek, E. Finanger

2026.4.27NEUROPEDIATRICS

DOI: 10.1055/s-0046-1822852

Abstract

Abstract is not available.

Citation format

GILLING, K., et al. Long-term safety of givinostat in patients with duchenne muscular dystrophy: Interim results from an open-label extension study. NEUROPEDIATRICS, 2026, 57(S 01): S1-S24.